PDA journal of pharmaceutical science and technology
ASEAN GMP and pharmaceutical industries in Indonesia
Abstract
Indonesia was appointed by the ASEAN Technical Cooperation in Pharmaceutical as a focal point and to coordinate the development of practical guidelines for the implementation of GMP. The ASEAN GMP Guidelines were endorsed by the ASEAN Technical Cooperation in Pharmaceutical in 1988, which among others required separation of Beta-Lactam dedicated facilities and three degrees of cleanliness for production areas. As it was realised that drug manufacturers in developing countries need more detailed guidelines to be able to implement the GMP, an Operational Manual for GMP was also prepared for providing examples of SOPs lay-outs, documentation etc. It was agreed by the technical cooperation group to leave the implementation of GMP to each member country. However, the ASEAN Manual for Inspection of GMP was drafted and endorsed by the group and training of ASEAN Drug Inspectors was organized to support the implementation. The ASEAN GMP is being implemented in Indonesia through a five-year, stepwise implementation plan, starting in 1989.
Source and rights
Published by PDA journal of pharmaceutical science and technology, 1995. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 1995
- Applies to
- 🇮🇩 Indonesia, 🇧🇳 Brunei, 🇰🇭 Cambodia, 🇱🇦 Laos, 🇲🇾 Malaysia, 🇲🇲 Myanmar (Burma), 🇵🇭 Philippines, 🇸🇬 Singapore, 🇹🇭 Thailand, 🇻🇳 Vietnam
- Scope
- Regional




